Many actions of cyclooxygenase-2 in cellular dynamics and in cancer.
about
Systemic therapy for cervical cancer with potentially regulatable oncolytic adenovirusesThe Role of PPARgamma Receptors and Leukotriene B(4) Receptors in Mediating the Effects of LY293111 in Pancreatic CancerNon-steroidal anti-inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasiaLipoxygenase and cyclooxygenase metabolism: new insights in treatment and chemoprevention of pancreatic cancerAllellic variants in regulatory regions of cyclooxygenase-2: association with advanced colorectal adenoma.Discoidin Domain Receptors: Potential Actors and Targets in CancerCommon Variants of the Prostaglandin-Endoperoxide Synthase 2 Gene and Hepatocellular Carcinoma SusceptibilityLung cancer: a classic example of tumor escape and progression while providing opportunities for immunological interventionIncreased NF-kappaB DNA binding but not transcriptional activity during apoptosis induced by the COX-2-selective inhibitor NS-398 in colorectal carcinoma cellsNonsteroidal anti-inflammatory drugs in colorectal cancer: from prevention to therapyOesophageal squamous cell neoplasia in head and neck cancer patients: upregulation of COX-2 during carcinogenesisPlants vs. cancer: a review on natural phytochemicals in preventing and treating cancers and their druggabilityAltered prostanoid signaling contributes to increased skin tumorigenesis in Tpl2 knockout miceThe bitter barricading of prostaglandin biosynthesis pathway: understanding the molecular mechanism of selective cyclooxygenase-2 inhibition by amarogentin, a secoiridoid glycoside from Swertia chirayita.Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence--data from a randomized clinical trialVEGF gene expression in adult human thymus fat: a correlative study with hypoxic induced factor and cyclooxygenase-2Inhibitory Effect of IFN-beta, on the Antitumor Activity of Celecoxib in U87 Glioma Model.Influence of age and gender on association between -765G > C COX-2 genetic polymorphism and gastric adenocarcinoma risk: a case-control study in Iran.Cyclooxygenase-2 and p53 expression as prognostic indicators in conventional renal cell carcinoma.Non-Steroidal Anti-Inflammatory Drugs in the Carcinogenesis of the Gastrointestinal Tract.PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3).The role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies.PGE2 receptor EP2 mediates the antagonistic effect of COX-2 on TGF-beta signaling during mammary tumorigenesis.Jacalin Has Chemopreventive Effects on Colon Cancer Development.Embryonic expression of cyclooxygenase-2 causes malformations in axial skeleton.Expression of cyclooxygenase-2 is associated with p53 accumulation in premalignant and malignant gallbladder lesionsExpression of 5-lipoxygenase in human colorectal cancer-765G > C COX-2 polymorphism may be a susceptibility marker for gastric adenocarcinoma in patients with atrophy or intestinal metaplasia.COX-2 gene expression in colon cancer tissue related to regulating factors and promoter methylation statusTransgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis.Epstein-Barr virus protein can upregulate cyclo-oxygenase-2 expression through association with the suppressor of metastasis Nm23-H1Anti-cancer effects of celecoxib on nasopharyngeal carcinoma HNE-1 cells expressing COX-2 oncoproteinExpression of cyclooxygenase-2 in colorectal cancer and its clinical significance.Humulone inhibits phorbol ester-induced COX-2 expression in mouse skin by blocking activation of NF-kappaB and AP-1: IkappaB kinase and c-Jun-N-terminal kinase as respective potential upstream targets.Mechanisms of oxysterol-induced carcinogenesis.Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion.COX-2-765G>C polymorphism increases the risk of cancer: a meta-analysis.Cyclooxygenase 2 selective inhibitors in cancer treatment and prevention.Biological roles of CCAAT/Enhancer-binding protein delta during inflammation.Cyclooxygenase-2 and B-cell lymphoma-2 expression in cystitis glandularis and primary vesicle adenocarcinoma.
P2860
Q21144267-909A1F38-0BA4-4AF7-A0E3-64DAF37064A6Q21342813-ACCAEA03-367E-4D87-949F-2A823BD6704BQ24197474-472FB80C-2082-4E2E-91E5-1E8C82F0424FQ24800010-7198E766-BB5F-4EC2-8783-FFB8EB075A42Q25255846-91709464-9113-4D7A-98A8-EAB13A99E386Q26751157-D9901CC9-6586-4581-B6D7-FF1D1C56DEECQ26786180-D3BEF367-5D93-4506-9A56-BA20FB4133D8Q26850218-9BE1C23D-92BE-41BC-A241-52E8DADBA5D8Q28165527-95E326AE-89C9-4132-9C1F-23F0399ED84BQ28195436-9A59140D-49C7-4348-A943-10218D6D0060Q28195678-4D875AF2-574A-4605-820A-AFB6DC8A42CBQ28385642-474185F5-54D2-4F8D-8691-1E5664B24CADQ28394475-24FA960C-3809-439D-AC02-EC500D6DFAF2Q28540582-35BF8E44-30FC-4B5F-A72B-0CFED47C4375Q33503521-19A21CB5-FE44-4472-BEAC-3EA2743BCF1EQ33518570-FC767469-24A0-4075-9E5A-372186DDEE00Q33577982-79F6D8CC-47C6-4DB6-BE96-0B17ABDB4FDEQ33596371-8D440DB5-FDA4-41A4-927D-AD74D87132D2Q33659189-91E3C549-10EE-4077-90D2-3B65E95645C7Q33664095-4C2275F2-2FDD-40B3-9415-55D6162DF0A1Q33705238-48A50E69-A253-4900-832D-D85943C0D09CQ33737469-03C79C3E-24FB-4EC9-8651-503396C32288Q33752909-30360D82-8E8B-4AD6-BE54-A7F94DA0B33EQ33813699-6B414143-A49F-473F-9CC2-005E91F882A1Q33855260-B8A36B07-E837-418B-AC23-C6F83D4B91F4Q33868003-F1980210-B180-43A9-9CA4-3B1871C49C18Q33869146-B2590120-1340-4D18-AD38-5859715968DEQ33869492-0F504868-9265-40B4-88FD-4F9CD4A83DD9Q33930978-3E710B96-C721-4536-B2BF-CE2F6312BB7BQ34156486-35C9C7B1-9F8A-4D9A-B976-A087C096640DQ34302223-39EB7918-D81C-4866-9E2F-12793F9CF263Q34361606-113E5468-6268-4C7F-8506-5AE67F75D15FQ34605197-399D620A-D6A0-4BB6-9A21-C14560717EC7Q34610297-4D4AFF58-3676-46BC-A5A8-B7AD96759609Q34704784-ECF46A7A-1202-459F-81B9-FE32A9E86F5CQ34761843-2ABA8C56-BD2A-45F4-A8E8-E8BF8817135AQ34984281-79D36484-0349-4755-B4C6-E35A01376A16Q35011895-DFDDC8CC-C157-43B5-87E5-636D3E667382Q35052847-3E20DE32-24E3-484B-AF7C-C82067A655E2Q35081466-B450AF7D-C983-4D98-9F0F-151D9B306422
P2860
Many actions of cyclooxygenase-2 in cellular dynamics and in cancer.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Many actions of cyclooxygenase-2 in cellular dynamics and in cancer.
@ast
Many actions of cyclooxygenase-2 in cellular dynamics and in cancer.
@en
Many actions of cyclooxygenase-2 in cellular dynamics and in cancer.
@nl
type
label
Many actions of cyclooxygenase-2 in cellular dynamics and in cancer.
@ast
Many actions of cyclooxygenase-2 in cellular dynamics and in cancer.
@en
Many actions of cyclooxygenase-2 in cellular dynamics and in cancer.
@nl
prefLabel
Many actions of cyclooxygenase-2 in cellular dynamics and in cancer.
@ast
Many actions of cyclooxygenase-2 in cellular dynamics and in cancer.
@en
Many actions of cyclooxygenase-2 in cellular dynamics and in cancer.
@nl
P356
P1476
Many actions of cyclooxygenase-2 in cellular dynamics and in cancer.
@en
P2093
Stephen M Prescott
P304
P356
10.1002/JCP.10068
P577
2002-03-01T00:00:00Z